Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplant.
Tembhare PR, Sriram H, Khanka T, Gawai S, Bagal B, Ghogale SG, Deshpande N, Girase K, Patil J, Hasan SK, Shetty D, Ghosh K, Chatterjee G, Rajpal S, Patkar NV, Jain H, Punatar S, Gokarn A, Nayak L, Mirgh S, Jindal N, Sengar M, Khattry N, Subramanian PG, Gujral S.
Tembhare PR, et al. Among authors: jindal n.
Hemasphere. 2024 Apr 1;8(4):e63. doi: 10.1002/hem3.63. eCollection 2024 Apr.
Hemasphere. 2024.
PMID: 38566804
Free PMC article.